Advertisement

Topics

Personalized Medicine Progressing in Premenopausal Breast Cancer

11:06 EDT 17 Apr 2019 | OncLive

Joyce A. O’Shaughnessy, MD, discusses the clinical implications of the TEXT and SOFT trials for women with premenopausal HR-positive, HER2-negative breast cancer, as well as unanswered questions that remain with adjuvant endocrine therapy.

Original Article: Personalized Medicine Progressing in Premenopausal Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Personalized Medicine Progressing in Premenopausal Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...